Parma signs 17-year-old Olympiacos player Paraskevas Pleionis

·

Paraskevas Pleionis will continue his career in Italy, who last season won the championship of Greece with the Olympiakos U17 team.

The Italian team reached an agreement with Olympiacos for the acquisition of the 17-year-old midfielder, so the young player, who made his presence felt in last year’s Super League U17 championship, is packing his bags for the neighboring country.

Share:

KEEP UP TO DATE WITH TGH

By subscribing you accept our Terms of Service and Privacy Policy.

Latest News

Echoes from the past: Owl skyphos from Athens

The owl is one of the most famous symbols of ancient Greece. Particularly associated with the goddess Athena.

Love, language and belonging: A Valentine’s Day story about choosing to be Greek

I must have been five, maybe six, watching my neighbour flip lamb on the barbecue while Greek music drifted from inside.

More than roses: How Greek Australian couples celebrate Valentine’s Day their way

The Greek Herald spoke with Greek Australian couples to hear their love stories and learn how their bonds have strengthened over time.

Bank of Sydney shares banking tips to help households and businesses in 2026

The latest inflation data confirms that price pressures are proving more stubborn than policymakers had anticipated.

Discover Athens food culture in a new cookbook‑memoir‑guide

This book is a collection of 150 recipes, but it is also much more than that. Kochilas calls it “part memoir, part reporting, and part guide” (9).

You May Also Like

Jimmy Coumvoulidis faces murder charge over fatal Dandenong stabbing

Jimmy Coumvoulidis, 34, from Blackburn South, has faced Melbourne Magistrates’ Court charged with the murder of a man.

Marcus Stoinis re-signs with Melbourne Stars for three years

Marcus Stoinis has extended his time at the Melbourne Stars to a 14th season after signing a three-year deal. Read more here.

World first trial for paediatric brain cancer launched in NSW

A world-first clinical trial, The Deflexifol® At Relapse Trial (DART), proudly supported by Kids with Cancer Foundation, has been launched.